Steven H. Bernstein

Steven H. Bernstein

Chief Tech/Sci/R&D Officer at 2SEVENTY BIO, INC.

Health Technology
Consumer Services
Health Services

Profile

Steven H.
Bernstein
is currently the Chief Medical Officer at 2seventy Bio, Inc. He previously worked as the Chairman of Immuno-Oncology Translational Research at Bristol Myers Squibb Co., a Professor of Medicine and Co-Director of Hematological at James P.
Wilmot Cancer Center, a Member of Lymphoma Working Group at SWOG, and the Chief Translational Officer at Turnstone Biologics Corp.
He received his undergraduate degree from Brandeis University and his doctorate from New York University School of Medicine.

Steven H. Bernstein active positions

CompaniesPositionStart
2SEVENTY BIO, INC. Chief Tech/Sci/R&D Officer 2022-02-13
All active positions of Steven H. Bernstein

Former positions of Steven H. Bernstein

CompaniesPositionEnd
Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
James P. Wilmot Cancer Center Corporate Officer/Principal -
TURNSTONE BIOLOGICS CORP. Chief Tech/Sci/R&D Officer -
See the detail of Steven H. Bernstein's experience

Training of Steven H. Bernstein

Brandeis University Undergraduate Degree
New York University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven H. Bernstein's experience

Connections

15

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

TURNSTONE BIOLOGICS CORP.

Health Technology

2SEVENTY BIO, INC.

Health Technology

Private companies2
James P. Wilmot Cancer Center

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Steven H. Bernstein